On August 5, 2025, Vaxart, Inc. received a stop work order from Advanced Technology International, halting efforts related to a specific project while allowing continuation of a COVID-19 vaccine trial for approximately 5,000 participants already enrolled. Details on the reason for the order are pending, but the independent Data Safety Monitoring Board confirmed the trial can proceed without modifications.